Literature DB >> 11174042

Stroke recovery profile and the Modified Rankin assessment.

S M Lai1, P W Duncan.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to examine the relationship between the Modified Rankin Scale (MRS) and poststroke recovery in neurological deficits, activities of daily living (ADL), higher level of physical and social functioning and the patients' preference for health state.
METHODS: Four hundred and fifty-nine participants in the Kansas City Stroke Study were prospectively assessed for measures of MRS, NIH Stroke Scale (NIHSS), Barthel ADL, SF-36 physical functioning, SF-36 social functioning, and Time Trade-Off (TTO). ANOVA and Bonferroni multiple comparisons were used to examine any differences in 3-month scores of NIHSS, Barthel ADL, SF-36 physical functioning, SF-36 social functioning and TTO between levels of the MRS. In addition, SF-36 physical functioning, SF-36 social functioning and TTO were characterized in patients who demonstrated improvement in global MRS outcome and also achieved a Barthel Index (BI) > or = 95 at 3 months after stroke.
RESULTS: Two hundred and eighty patients (62%) shifted at least one grade in MRS from baseline to 3 months after stroke. Only 67 or 194 patients were considered to have a favorable outcome using MRS 0/1 or MRS 0/1/2, respectively, as criteria. Mean 3-month NIHSS and Barthel ADL scores were not significantly different between Rankin 0/1 and 2, but they were significantly different among Rankin 3, 4 and 5 (all p < 0.05). Mean 3-month scores of physical functioning and SF-36 social functioning were significantly different among Rankin 0/1, 2, 3 and 4 (all pairwise p < 0.05). Proportions of patients who achieved NIHSS < or = 1 or BI > or = 95 decreased as MRS grades worsened. In patients who showed improvement in MRS global outcome and also achieved BI > or = 95, mean scores on TTO were similar.
CONCLUSIONS: Definition of favorable outcomes should include transition in the Modified Rankin score rather than MRS dichotomized as 0/1 or 0/1/2 because patients with transition in MRS scores have improvement in ADL, increased higher level of functioning and higher utility for health state.

Entities:  

Mesh:

Year:  2001        PMID: 11174042     DOI: 10.1159/000054754

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  26 in total

1.  Pre-post evaluation of automated reminders may improve detection and management of post-stroke depression.

Authors:  Linda S Williams; Susan Ofner; Zhangsheng Yu; Rebecca J Beyth; Laurie Plue; Teresa Damush
Journal:  J Gen Intern Med       Date:  2011-08       Impact factor: 5.128

2.  Clinical features of systemic cancer patients with acute cerebral infarction and its underlying pathogenesis.

Authors:  Yajuan Chen; Jinsheng Zeng; Xingrui Xie; Zijun Wang; Xiaoting Wang; Zhijian Liang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Functional Neurologic Outcomes Change Over the First 6 Months After Cardiac Arrest.

Authors:  Julia T Tong; Irina Eyngorn; Michael Mlynash; Gregory W Albers; Karen G Hirsch
Journal:  Crit Care Med       Date:  2016-12       Impact factor: 7.598

4.  A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy.

Authors:  Kate C Young; Robert G Holloway; W Scott Burgin; Curtis G Benesch
Journal:  J Stroke Cerebrovasc Dis       Date:  2010 Sep-Oct       Impact factor: 2.136

5.  The cost-effectiveness of telestroke in the treatment of acute ischemic stroke.

Authors:  R E Nelson; G M Saltzman; E J Skalabrin; B M Demaerschalk; J J Majersik
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

6.  Disability status at 1 month is a reliable proxy for final ischemic stroke outcome.

Authors:  Bruce Ovbiagele; Patrick D Lyden; Jeffrey L Saver
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

7.  Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference.

Authors:  Julie K Tilson; Katherine J Sullivan; Steven Y Cen; Dorian K Rose; Cherisha H Koradia; Stanley P Azen; Pamela W Duncan
Journal:  Phys Ther       Date:  2009-12-18

8.  Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.

Authors:  A I Qureshi; Y Y Palesch
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

9.  Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients.

Authors:  Justin D Salciccioli; Michael N Cocchi; Jon C Rittenberger; Mary Ann Peberdy; Joseph P Ornato; Benjamin S Abella; David F Gaieski; John Clore; Shiva Gautam; Tyler Giberson; Clifton W Callaway; Michael W Donnino
Journal:  Resuscitation       Date:  2013-06-21       Impact factor: 5.262

10.  Central nervous system angiitis: a series of 31 patients.

Authors:  Guillaume Geri; David Saadoun; Rémy Guillevin; Sophie Crozier; Catherine Lubetzki; Karima Mokhtari; Zahir Amoura; Bertrand Wechsler; Du Le Boutin; Nathalie Costedoat-Chalumeau; Yves Samson; Patrice Cacoub
Journal:  Clin Rheumatol       Date:  2013-10-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.